Zenith Healthcare Ltd Approves Scheme of Amalgamation of Achyut Healthcare Limited

Zenith Healthcare Ltd Approves Scheme of Amalgamation of Achyut Healthcare Limited​

Zenith Healthcare Ltd announced on July 14, 2026, that its Board of Directors approved a comprehensive Scheme of Amalgamation involving Achyut Healthcare Limited. The transaction involves the merger of Achyut Healthcare Limited (the Transferor Company) into Zenith Healthcare Limited (the Transferee Company).

The amalgamation aims to consolidate operations and expand market reach for both entities, driven by shared business operations within the pharmaceutical industry. The Scheme mandates the dissolution of Achyut Healthcare Limited without winding up. In consideration for the merger, Zenith Healthcare Limited will issue fully paid-up Equity Shares at a face value of INR 1/- each to the equity shareholders of Achyut Healthcare Limited.

Financial and Operational Overview​

The transaction involves two entities operating in related pharmaceutical fields. The board meeting held on July 14, 2026, reviewed the Scheme following recommendations from the Audit Committee and the Committee of Independent Directors.

Key financial details and operational profiles for both companies as of March 31, 2026 are summarized below:


The transaction is categorized as a related party transaction, as the promoters of both companies belong to the same group. The consideration for the amalgamation has been determined on an arm's length basis, and no cash consideration is payable under the Scheme. The Share Exchange Ratio was based on a report issued by registered valuers Den Valuation (OPC) Private Limited and Vanshika Vijayvargiy, along with a Fairness Opinion provided by Aftertrade Broking Private Limited.

Business Scope and Strategic Rationale​

The Transferor Company's business includes trading and dealing in active pharmaceutical ingredients (APIs) and pharmaceutical products. Furthermore, the company is undertaking the installation and commissioning of plants to manufacture General Tablets, Effervescent Tablets, Capsules, Liquid Inhalation, and Sachet at a facility in Ahmedabad, compliant with WHO cGMP certification standards.

Zenith Healthcare Limited is engaged in the manufacturing, marketing, sale, and export of pharmaceutical products and medical preparations.

The companies decided on the amalgamation due to their similar or related business sectors. The anticipated benefits of merging include:

• Efficiency and Growth: Increased revenues, operational efficiency, and enhanced product portfolios for both entities.
• Market Access: The amalgamation is expected to enable the Transferee Company to access larger production capacity and specialized products ranges through Achyut’s facility.
• Synergies: Streamlining of legal and regulatory compliances and optimization of procurement, manufacturing, and distribution networks across both companies.
• Financial Strength: Creating a unified and stronger balance sheet for the combined entity, improving financial capacity and access to capital.

The Scheme is subject to necessary approvals from statutory and regulatory authorities, including the jurisdictional bench of the National Company Law Tribunal (NCLT), as well as the approval of shareholders and creditors.

Stock Price Movement​

Zenith Healthcare Ltd saw its shares settle on Tuesday at ₹3.05 after shedding 2.24% of its value. The stock traded within an intraday range, moving from a low of ₹2.92 to a high of ₹3.06.